Cargando…
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
MYC regulates multiple gene programs, raising questions about the potential selectivity and downstream transcriptional consequences of MYC inhibitors as cancer therapeutics. Here, we examined the effect of a small-molecule MYC inhibitor, MYCi975, on the MYC/MAX cistromes, epigenome, transcriptome, a...
Autores principales: | Holmes, Austin G., Parker, J. Brandon, Sagar, Vinay, Truica, Mihai I., Soni, Pritin N., Han, Huiying, Schiltz, Gary E., Abdulkadir, Sarki A., Chakravarti, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045724/ https://www.ncbi.nlm.nih.gov/pubmed/35476451 http://dx.doi.org/10.1126/sciadv.abh3635 |
Ejemplares similares
-
KLF15 cistromes reveal a hepatocyte pathway governing plasma corticosteroid transport and systemic inflammation
por: Jiang, Zhen, et al.
Publicado: (2022) -
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
por: Welcker, Markus, et al.
Publicado: (2022) -
Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias
por: Nishida, Yuki, et al.
Publicado: (2023) -
Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019) -
Integrative mapping of the dog epigenome: Reference annotation for comparative intertissue and cross-species studies
por: Son, Keun Hong, et al.
Publicado: (2023)